A newly presented exploratory cohort analysis showed that individuals who were apolipoprotein (APOE) ϵ4/ϵ4 carriers were significantly more likely to have biomarker results indicating symptomatic or at-risk status for mild cognitive impairment…
APOE ϵ4/ϵ4 Predicts Higher Alzheimer Risk, But Many Without Allele Have True AD Pathology, Study Shows | NeurologyLive
